Literature DB >> 12620174

Achieving the best outcome in treatment of depression.

John E Sutherland1, Steven J Sutherland, James D Hoehns.   

Abstract

Combined treatment with psychotherapy or psychiatric consult and drug therapy has shown better response in several studies than either therapy alone. Although not proven by clinical trials, selecting a medication by matching its side-effect profile to patient characteristics is supported by case reports and likely enhances compliance. Patients who do not improve with initial therapy often benefit from being switched to another class of antidepressants, or having a drug from another class added to their therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620174

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  2 in total

1.  Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder.

Authors:  Rafał Świechowski; Agnieszka Jeleń; Marek Mirowski; Monika Talarowska; Piotr Gałecki; Jacek Pietrzak; Damian Wodziński; Ewa Balcerczak
Journal:  Mol Genet Genomic Med       Date:  2019-04-25       Impact factor: 2.183

2.  Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia.

Authors:  Fahad D Alosaimi; Abdulhadi Alhabbad; Mohammed F Abalhassan; Ebtihaj O Fallata; Nasser M Alzain; Mohammad Zayed Alassiry; Bander Abdullah Haddad
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.